NEW YORK–(BUSINESS WIRE)—June 28, 2024–The Cannabist Company Holdings Inc. (NEO: CBST) (OTCQX:CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced today that, at the annual general meeting (the “Meeting”) of shareholders of the Company (“Shareholders”) that was held on Wednesday, June 26, 2024, all nine nominees for the board of directors of the Company were elected, the voting results of which are as follows:
Notes:
(1) Assuming conversion of all proportionate voting shares into common shares.
Shareholders also approved the re-appointment of Davidson & Company LLP as auditor of the Company for the ensuing year
and the authorization of directors to fix their remuneration.
Full details of the foregoing are contained in the Report of Voting Results for the Meeting which has been filed on SEDAR+
at www.sedarplus.com.
About The Cannabist Company (f/k/a Columbia Care)
The Cannabist Company, formerly known as Columbia Care, is one of the largest and most experienced cultivators,
manufacturers and providers of cannabis products and related services, with licenses in 15 U.S. jurisdictions. The Company
operates 121 facilities including 90 dispensaries and 31 cultivation and manufacturing facilities, including those under
development. Columbia Care, now The Cannabist Company, is one of the original multi-state providers of cannabis in the U.S.
and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the Company
launched Cannabist, its retail brand, creating a national dispensary network that leverages proprietary technology platforms.
The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed &
Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. For more information, please visit
www.cannabistcompany.com.
